SEARCH

SEARCH BY CITATION

References

  • 1
    Fielding CL, Pusterla N, Magdesian KG, et al. Rattlesnake envenomation in horses: 58 cases (1992–2009). J Am Vet Med Assoc 2011;238:631635.
  • 2
    Dickinson CE, Traub-Dargatz JL, Dargatz DA, et al. Rattlesnake venom poisoning in horses: 32 cases (1973–1993). J Am Vet Med Assoc 1996;208:18661871.
  • 3
    Hackett TB, Wingfield WE, Mazzaferro EM, Benedetti JS. Clinical findings associated with prairie rattlesnake bites in dogs: 100 cases (1989–1998). J Am Vet Med Assoc 2002;11:16751680.
  • 4
    Weinstein SA, Dart RC, Staples A, White J. Envenomations: An overview of clinical toxinology for the primary care physician. Am Fam Physician 2009;80:793802.
  • 5
    Vincent JL. Intensive Care Medicine. New York: Springer-Verlag; 2002.
  • 6
    Lawler JB, Frye MA, Bera MM, et al. Third-degree atriventricular block in a horse secondary to rattlesnake envenomation. J Vet Intern Med 2008;22:486490.
  • 7
    Rashmir-Raven AM, Brashier M. Veterinary medicine today: ECG of the month. J Am Vet Med Assoc 2000;217:830832.
  • 8
    Willey JR, Schaer M. Eastern diamondback rattlesnake (Crotalus adamanteus) envenomation of dogs: 31 cases (1982–2002). J Am Anim Hosp Assoc 2005;41:2233.
  • 9
    Dykgraaf S, Pusterla N, Hoogmoed LMv. Rattlesnake envenomation in 12 New World camelids. J Vet Intern Med 2006;20:9981002.
  • 10
    Zhang P, Lader AS, Etcheverry MA, et al. Crotoxin potentiates L-type calcium currents and modulates the action potential of neonatal rat cardiomyocytes. Toxicon 2010;55:12361243.
  • 11
    Harvey AL. Reptile Venoms and Toxins. New York: Marcel Dekker, Inc; 1991.
  • 12
    Divers TJ, Kraus MS, Radcliffe RM, et al. Measurement and clinical use of cardiac troponin I (cTnI) in horses. Proceedings of the 56th Annual Convention of the American Association of Equine Practitioners, Baltimore, MD, 4–8 December 2010:277278.
  • 13
    Tacker WJ, Van Vleet J, Geddes L. Electrocardiographic and serum enzyme alterations associated with cardiac alterations induced in dogs by single transthoracic damped sinusoidal defibrillator shocks of various strengths. Am Heart J 1979;98:185193.
  • 14
    Ettinger S, Feldman E. Biochemical markers of cardiovascular disease. In: Schober K, ed. Textbook of Veterinary Internal Medicine, 6th ed. St. Louis, MO: Elsevier; 2005:940948.
  • 15
    Fonfara S, Loureiro J, Swift S, et al. Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs. Vet J 2010;184:334339.
  • 16
    Pelander L, Ljungvall I, Haggstrom J. Myocardial cell damage in 24 dogs bitten by the common European viper (Vipera berus). Vet Rec 2010;166:687690.
  • 17
    Smith BP. Large Animal Internal Medicine, 4th ed. St. Louis, MO: Mosby Elsevier; 2009.
  • 18
    MouradaSilva AM, Laing GD, Paine MJI, et al. Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: A hypothesis explaining local tissue damage following snake bite. Eur J Immunol 1996;26:20002005.
  • 19
    Szold O, Ben-Abraham R, Frolkis I, et al. Tumor necrosis factor as a mediator of cardiac toxicity following snake envenomation. Crit Care Med 2003;31:14491453.
  • 20
    Dos-Santos MC, Yamaquchi IK, Caricatti CP, et al. Immunization of equines with phospholipase A2 protects against the lethal effects of Crotalus durissus terrificus venom. Braz J Med Biol Res 1989;22:509512.
  • 21
    Holbrook TC, Birks EK, Sleeper MM, Durando M. Endurance exercise is associated with increased plasma cardiac troponin I in horses. Equine Vet J Suppl 2006;36:2731.
  • 22
    Durando MM, Slack J, Reef VB, Birks EK. Right ventricular pressure dynamics and stress echocardiography in pharmacological and exercise stress testing. Equine Vet J Suppl 2006;36:183192.
  • 23
    Wells SM, Sleeper MM. Cardiac troponins. J Vet Emerg Crit Care 2008;18:235245.
  • 24
    McFarlane D, Holbrook TC. Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction. J Vet Intern Med 2008;22:436432.
  • 25
    Durando MM, Birks E.KHussey SB, Lunn DP. Cardiac troponin I concentrations in ponies challenged with equine influenza virus. J Vet Intern Med 2011;25:339344.
  • 26
    Nostell K, Brojer JHoglund K, et al. Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia. Vet J 2011;192:171175.
  • 27
    Kraus MS, Jesty SA, Gelzer AR, et al. Measurement of plasma cardiac troponin I concentration by use of a point-of-care analyzer in clinically normal horses and horses with experimentally induced cardiac disease. Am J Vet Res 2010;71:5559.
  • 28
    Fennell L, Forbes G. Use of cardiac troponin to aid diagnosis of heart disease in horses. Aust Equine Vet 2009;28:4447.
  • 29
    Holbrook TC. Cantharidin toxicosis in horses: Pathogenesis, diagnosis & treatment. Proceedings ACVIM Forum, San Antonio, TX, 4–7 June, 2008 Veterinary Proceedings 2008:210212.
  • 30
    Serra M, Papakonstantinou S, Adamcova M, O'Brien PJ. Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin. Vet J 2010;185:5057.
  • 31
    Rajappa M, Sharma A. Biomarkers of cardiac injury: An update. Angiology 2005;56:677691.
  • 32
    Fonfara S, Loureiro J, Swift S, et al. Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs. Vet J 2010;184:334339.
  • 33
    Seifert SA, Boyer L.V. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med 2001;37:189195.
  • 34
    Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline fab antivenom. Ann Emerg Med 2001;37: 196201.
  • 35
    Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993;21:S423S435.
  • 36
    Fernandez-Velasco M, Ruiz-Hurtado G, Hurtado O, et al. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol Heart Circ Physiol 2007;293:H238H245.
  • 37
    Oral H, Kapadia S, Nakano M, et al. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995;18:IV20IV27.
  • 38
    Andrade ZA, Andrade SG, Correa R, et al. Myocardial changes in acute Trypanosoma cruzi infection. Am J Pathol 1994;144:14031411.
  • 39
    Ownby CL, Reisbeck SL, Allen R. Levels of therapeutic antivenin and venom in a human snakebite victim. South Med J 1996;89:803806.
  • 40
    Posner P, MacIntosh B, GA G. Effects of Western diamondback rattlesnake (Crotalus atrox) venom on heart muscle. Toxicon 1981;19:330333.
  • 41
    Singletary EM, Rochman AS, Arias Bodmer JC, Holstege CP. Envenomations. Med Clin N Am 2005;89:11951224.
  • 42
    Russell FE. Snake venom poisoning in the United States. Annu Rev Med 1980;31:247259.
  • 43
    Segev G, Ohad DG, Shipov A, et al. Cardiac arrhythmias and serum cardiac troponins in Vipera palaestinae envenomation in dogs. J Vet Intern Med 2008;22:106113.
  • 44
    Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391394.